Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00694382

Completed

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy (SAVE-ONCO)

Cancer | Venous Thromboembolism
NCT00396591

Completed

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Ovarian Neoplasms
NCT00284141

Completed

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Neoplasms, Lung | Pulmonary Diseases
NCT00912119

Completed

Amicar Pharmacokinetics of Children Having Craniofacial Surgery

Craniosynostosis
NCT00211458

Completed

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration
NCT01131585

Terminated

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RELATION)

Visual Impairment Due to Diabetic Macular Edema
NCT01372761

Completed

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

Obesity
NCT01060163

Completed

Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion (TRACED)

Coronary Artery Disease
NCT01029821

Unknown

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

Deep Venous Thrombosis
NCT01017107

Completed

Activated Protein C in Severe Acute Pancreatitis

Acute Pancreatitis
NCT01031992

Completed

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

Hereditary Hemorrhagic Telangiectasia
NCT01027481

Completed

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Retinal Vein Occlusion
NCT00885300

Completed

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

Hemodialysis | Double Lumen Infection
NCT00279578

Completed

Clot Formation and Clot Stability in Patients With Severe Haemophilia A

Hemophilia A
NCT07648446

Recruiting

Pulse Education and Children

Dysbiosis | Education on Feeding and Health Status | Cardiometabolic Health Indicators | Gut Motility
NCT05665478

Not yet recruiting

Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients

Febrile Neutropenia | Pharmacokinetics | Pharmacodynamic | Carbapenems
NCT07254169

Enrolling by invitation

The Efficacy and Safety of Herbal Medicine Treatment Strategy for Patients With Post-Accident Fatigue (TA fatigue)

Post-traffic Accident Fatigue
NCT04088669

Completed

Efficiency of Home-Based Pulmonary Rehabilitation in Adults With Asthma

Asthma | Pulmonary Rehabilitation | Home-based Pulmonary Rehabilitation
NCT02469753

Completed

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes (STOP)

Ankylosing Spondylitis
NCT06490159

Recruiting

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

Gastric Cancer | Chemotherapy-induced Peripheral Neuropathy | Ramucirumab | Paclitaxel
NCT04490707

Recruiting

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Acute Myeloid Leukemia in Remission
NCT03353831

Completed

Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

Recurrent Ovarian Carcinoma
NCT03502746

Terminated

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

Mesothelioma, Malignant
NCT04033991

Completed

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Carcinoma | Renal Cell
NCT02432846

Completed

Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) (MERECA)

Renal Cell Carcinoma, Metastatic
NCT01396148

Completed

A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors
NCT01164007

Completed

A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Malignant Melanoma
NCT01016600

Completed

Azacitidine and Lenalidomide for Acute Myeloid Leukemia

Leukemia, Myeloid, Acute
NCT00570882

Completed

Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)

Metastatic Renal Cell Carcinoma
NCT00732914

Completed

Sequential Study to Treat Renal Cell Carcinoma

Renal Cell Carcinoma
NCT00532909

Completed

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Colorectal Neoplasms | Anal, Colon, and Rectal Cancers | Colon/Rectal Cancer
NCT00684307

Completed

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Nonvalvular Atrial Fibrillation
NCT00444314

Completed

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma
NCT00253903

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year (EPLILONG)

Insomnia | Sleep Initiation and Maintenance Disorders
NCT05803655

Recruiting

Outcomes of 36 vs 38 Hour Intervals From Ovulation Trigger To Oocyte Pick-Up:A Multi-Center Randomized Controlled Trial

Infertility | IVF
NCT06339424

Recruiting

Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma (PhotonAB)

Hepatocellular Carcinoma
NCT04732286

Terminated

A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Carcinoma, Hepatocellular
NCT04925284

Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Cervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC
NCT03272217

Terminated

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

Urothelial Carcinoma
NCT05547750

Completed

Effect of Vitamin K2 in the Treatment of Nocturnal Leg Cramps in Older Population

Nocturnal Leg Cramps
NCT02401815

Completed

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Gastrointestinal Stromal Tumors
NCT03677934

Completed

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)

Neovascular Age-Related Macular Degeneration
NCT04496921

Withdrawn

Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis (VITK-FK)

Cystic Fibrosis
NCT01528800

Completed

Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients (iPACK-HD)

End-stage Kidney Disease
NCT00853125

Terminated

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
NCT03708536

Withdrawn

Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma

Colorectal Adenocarcinoma
NCT04357002

Unknown

Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy

Myomectomy
NCT02591914

Completed

An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration
NCT00578526

Completed

SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial (SPRUCE)

Bladder Cancer | Urothelial Cancer | Adult
NCT00203411

Completed

Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer

Colorectal Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations